A Randomized, Double-Blind, Parallel-Group Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of CMAB015, a Candidate Secukinumab Biosimilar, with Its Reference Product Cosentyx® in Healthy Chinese Male Subjects

• Main Authors: Yao F (Author), Wang C (Author), Ding J (Author), Zhang Q (Author), Zheng L (Author), Yang T (Author), Zhang X (Author), Shan Y (Author), Hou S (Author), Wang H (Author), Zhou R (Author), Hu W (Author)
• Format: Book
• Published: Dove Medical Press, 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Feng Yao,1,* Chenguang Wang,2,* Jie Ding,1 Qian Zhang,1 Liang Zheng,1 Qin Zhang,1 Tianshu Yang,2 Xunmin Zhang,2 Yong Shan,2 Sheng Hou,2 Hao Wang,2 Renpeng Zhou,1 Wei Hu1 1Department of Clinical Pharmacology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People�...